IBRNvsIDEV
iShares Neuroscience and Healthcare ETF against iShares Core MSCI International Developed Markets ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | IDEV | |
|---|---|---|
| Expense ratio | 0.47% | 0.040% |
| Assets | $9M | $34B |
| Net flow, 1 month | +$2M | +$587M |
| Net flow, 1 year | +$4M | +$8B |
| Return, YTD | +3.6% | +7.2% |
| Return, 1 year | — | — |
| Avg daily volume | 4K | 2.2M |
| Holdings | 67 | 2310 |
| Listed | Aug 24, 2022 | Mar 21, 2017 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS